Your browser doesn't support javascript.
loading
Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series.
Kaenkumchorn, Tanyaporn; Suskind, David L; Lee, Dale; Singh, Namita; Ford, Madeline; Skeen, Kristina; Macris, Paula C; Yeung, Cecilia; Summers, Corinne; Carpenter, Paul A; Zheng, Hengqi B.
Afiliação
  • Kaenkumchorn T; From the Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
  • Suskind DL; From the Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
  • Lee D; From the Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
  • Singh N; From the Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
  • Ford M; From the Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
  • Skeen K; Clinical Nutrition, Seattle Children's Hospital, Seattle, WA.
  • Macris PC; Medical Nutrition Therapy Services, Seattle Cancer Care Alliance, Seattle, WA.
  • Yeung C; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Summers C; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Carpenter PA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Zheng HB; From the Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
JPGN Rep ; 3(2): e203, 2022 May.
Article em En | MEDLINE | ID: mdl-37168898
ABSTRACT
Acute gastrointestinal graft-versus-host disease (GI GVHD) is a complication after hematopoietic stem cell transplant with high morbidity and mortality. In particular, steroid-refractory GI GVHD can be difficult to treat. Recent investigations have revealed that patients after transplant can experience intestinal dysbiosis contributing to the progression of GVHD. Modulation of the gut microbiome through dietary intake could potentially improve the intestinal dysbiosis in GI GVHD. In this case series, we present 3 patients where dietary therapy was used in conjunction with immunosuppression to achieve clinical remission of GI GVHD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: JPGN Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: JPGN Rep Ano de publicação: 2022 Tipo de documento: Article